<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>LENUS Collection:</title>
    <link>http://hdl.handle.net/10147/137017</link>
    <description />
    <pubDate>Mon, 20 May 2013 16:33:13 GMT</pubDate>
    <dc:date>2013-05-20T16:33:13Z</dc:date>
    <item>
      <title>Pancreatico pleural fistula an unusual complication of chronic pancreatitis</title>
      <link>http://hdl.handle.net/10147/239275</link>
      <description>Title: Pancreatico pleural fistula an unusual complication of chronic pancreatitis
Authors: Ferris, H; Buckley, M</description>
      <pubDate>Sun, 01 Jul 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/239275</guid>
      <dc:date>2012-07-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation.</title>
      <link>http://hdl.handle.net/10147/206360</link>
      <description>Title: Incidence and predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular block and dual chamber pacemaker implantation.
Authors: Radeljic, Vjekoslav; Pavlovic, Nikola; Manola, Sime; Delic-Brkljacic, Diana; Pintaric, Hrvoje; Petrac, Dubravko
Abstract: AIM: To evaluate predictors of asymptomatic atrial fibrillation in patients older than 70 years with complete atrioventricular (AV) block, normal left ventricular  systolic function, and implanted dual chamber (DDD) pacemaker. METHODS: Hundred and eighty six patients with complete AV block were admitted over one year to the Sisters of Mercy University Hospital. The study recruited patients older than 70  years, with no history of atrial fibrillation, heart failure, or reduced left ventricular systolic function. All the patients were implanted with the same pacemaker. Out of 103 patients who were eligible for the study, 81 (78%) were evaluated. Among those 81 (78%) were evaluated. Eighty one (78%) patients were evaluated. Follow-up time ranged from 12 to 33 months (average +/-standard deviation 23 +/- 5 months). Primary end-point was asymptomatic atrial fibrillation occurrence recorded by the pacemaker. Atrial fibrillation occurrence was defined as atrial high rate episodes (AHRE) lasting &gt;5 minutes. Binary logistic regression was used to identify the predictors of development of asymptomatic atrial fibrillation. Results. The 81 patients were stratified into two groups depending on the presence of AHRE lasting &gt;5 minutes (group 1 had AHRE&gt;5 minutes and group 2 AHRE&lt;5 minutes). AHRE lasting &gt;5 minutes were detected in 49 (60%) patients after 3 months and in 53 (65%) patients after 18 moths. After 3 months, only hypertension (odds ratio [OR], 17.63; P = 0.020) was identified as a predictor of asymptomatic atrial fibrillation. After 18 months, hypertension (OR, 14.0; P = 0.036), P wave duration &gt;100 ms in 12 lead ECG (OR, 16.5; P = 0.001), and intracardial atrial electrogram signal amplitude &gt;4 mV (OR, 4.27; P = 0.045) were identified as predictors of atrial fibrillation. CONCLUSION: In our study population, hypertension was the most robust and constant predictor of asymptomatic atrial fibrillation after 3 months, while P wave duration &gt;100 ms in 12-lead ECG and intracardial atrial signal amplitude were predictors after 18 months.</description>
      <pubDate>Tue, 31 Jan 2012 16:40:09 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/206360</guid>
      <dc:date>2012-01-31T16:40:09Z</dc:date>
    </item>
    <item>
      <title>An unusual pelvic mass: bladder lymphoma.</title>
      <link>http://hdl.handle.net/10147/206354</link>
      <description>Title: An unusual pelvic mass: bladder lymphoma.
Authors: Alsinnawi, M; Quinlan, M; Brady, A; Khan, N</description>
      <pubDate>Tue, 31 Jan 2012 16:40:06 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/206354</guid>
      <dc:date>2012-01-31T16:40:06Z</dc:date>
    </item>
    <item>
      <title>Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.</title>
      <link>http://hdl.handle.net/10147/206374</link>
      <description>Title: Preclinical evaluation of gene delivery methods for the treatment of loco-regional disease in breast cancer.
Authors: Rajendran, Simon; O'Hanlon, Deirdre; Morrissey, David; O'Donovan, Tracey; O'Sullivan, Gerald C; Tangney, Mark
Abstract: Preclinical results with various gene therapy strategies indicate significant potential for new cancer treatments. However, many therapeutics fail at clinical  trial, often due to differences in tissue physiology between animal models and humans, and tumor phenotype variation. Clinical data relevant to treatment strategies may be generated prior to clinical trial through experimentation using intact patient tissue ex vivo. We developed a novel tumor slice model culture system that is universally applicable to gene delivery methods, using a realtime  luminescence detection method to assess gene delivery. Methods investigated include viruses (adenovirus [Ad] and adeno-associated virus), lipofection, ultrasound (US), electroporation and naked DNA. Viability and tumor populations within the slices were well maintained for seven days, and gene delivery was qualitatively and quantitatively examinable for all vectors. Ad was the most efficient gene delivery vector with transduction efficiency &gt;50%. US proved the optimal non-viral gene delivery method in human tumor slices. The nature of the ex vivo culture system permitted examination of specific elements. Parameters shown to diminish Ad gene delivery included blood, regions of low viability and secondary disease. US gene delivery was significantly reduced by blood and skin,  while tissue hyperthermia improved gene delivery. US achieved improved efficacy for secondary disease. The ex vivo model was also suitable for examination of tissue-specific effects on vector expression, with Ad expression mediated by the  CXCR4 promoter shown to provide a tumor selective advantage over the ubiquitously active cytomegalovirus promoter. In conclusion, this is the first study incorporating patient tissue models in comparing gene delivery from various vectors, providing knowledge on cell-type specificity and examining the crucial biological factors determining successful gene delivery. The results highlight the importance of in-depth preclinical assessment of novel therapeutics and may serve as a platform for further testing of current, novel gene delivery approaches.</description>
      <pubDate>Tue, 31 Jan 2012 16:40:04 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10147/206374</guid>
      <dc:date>2012-01-31T16:40:04Z</dc:date>
    </item>
  </channel>
</rss>

